2BB score and signals
Autolus Therapeutics’s current 2BB score is 29 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 7 | Very Low |
| Momentum | 42 | Stable |
| Financial strength | 24 | Weak |
| Quality | 100 | Very Strong |
| Risk | 57 | Moderate |
Autolus Therapeutics (AUTL) Stock Score & Signals
Autolus Therapeutics (AUTL) trades on NASDAQ. It operates in the Health Care sector, Biotechnology: Biological Products (No Diagnostic Substances) industry. Its current 2BB score is 29 out of 100.
Company facts
| CEO | Christian Itin |
| Founded | 2014 |
| Employees | 753 |
| 52-week range | $1.18 – $2.43 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2026-11-10 | — | -0.1739 | — | $39.96M |
| 2026-08-11 | -0.15 | -0.22 | $45.69M | $34.70M |